Search results
Competitor to Merck's Keytruda Worries Some Investors
Barrons.com· 7 days agoInvestors in Merck don't seem pleased with a competitor cancer-treatment candidate outperforming...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 3 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 3 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 2 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 2 days agoFriday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 3 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 13 hours agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
Descending networks transform command signals into population motor control - Nature
Nature· 1 day agoThe day before optogenetic experiments (22–26 h prior), we transferred experimental and control61 flies to a vial containing food covered with 20 μl all trans-retinal (ATR) solution (100 mM ...
Could AI put an end to animal testing?
BBC via Yahoo News· 3 hours agoHowever, Kerstin Kleinschmidt-Dorr, chief veterinary officer at German pharmaceutical company Merck, says that animal testing cannot disappear overnight....